Title : Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer.

Pub. Date : 2015 Jun 20

PMID : 25962959






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dinaciclib, a novel small molecule inhibitor of CDK1, CDK2, CDK5 and CDK9, is assessed in clinical trials for the treatment of several types of cancers. dinaciclib cyclin dependent kinase 9 Homo sapiens